Earlier this month I reported a story at Refugee Resettlement Watch about a Nepalese man getting across the Mexican border with multidrug-resistant Tuberculosis (click here to read that post). All of the border agents and as many people as they could find who came in contact with him had to be tested. It seems that he may be the tip of the iceberg.
Writing at the Wall Street Journal, reporter Betsy McKay has been doing fantastic work following the near epidemic proportions the disease is reaching in some hot spots around the world. Although the number of cases is still small in the US—124 in 2011—Mexico’s cases are on the rise and it’s no surprise that the largest percentage of the drug-resistant cases in the US are, according to the Wall Street Journal, in California and Texas.
If you are a WSJ subscriber the link for the whole story is here.
According to the Centers for Disease Control and reported by McKay, to treat one case of multidrug-resistant TB will cost us (the taxpayers) $140,000 to as high as $700,000 per patient!
And, what are the odds that that asylum seeker from Nepal which the WSJ highlighted previously will be sent back to Nepal? Slim to none!
And, by the way, we are allowing resettlement of refugees with TB (HIV too).
It sure is a good thing we have Obamacare now to take care of all these sick immigrants!
Update March 11th: CDC warns of SARS coming from the Middle East.